HS GovTech Solutions Inc.
HS GovTech Solutions Inc. (HS.CN) Stock Competitors & Peer Comparison
See (HS.CN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HS.CN | CA$0.53 | +3.92% | 29M | -3.31 | -CA$0.16 | N/A |
| VHI.TO | CA$13.47 | -0.88% | 768.2M | 349.00 | CA$0.04 | N/A |
| KSI.TO | CA$5.60 | -6.98% | 560.5M | 590.00 | CA$0.01 | N/A |
| CARE.TO | CA$5.15 | +0.10% | 345.7M | -17.15 | -CA$0.30 | N/A |
| TRUE.CN | CA$0.49 | +2.08% | 36.2M | -2.53 | -CA$0.19 | N/A |
| NARA.CN | CA$1.45 | -0.68% | 21.4M | -1.95 | -CA$0.78 | N/A |
| UDOC.CN | CA$0.23 | +0.00% | 17.5M | -2.56 | -CA$0.09 | N/A |
| RYAH.CN | CA$0.03 | +0.00% | 11.2M | -0.15 | -CA$0.17 | N/A |
| AIML.CN | CA$0.05 | +0.00% | 7.8M | -0.75 | -CA$0.06 | N/A |
| TELE.CN | CA$0.09 | N/A | 7.6M | -0.13 | -CA$0.69 | N/A |
Stock Comparison
HS.CN vs VHI.TO Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, VHI.TO has a market cap of 768.2M. Regarding current trading prices, HS.CN is priced at CA$0.53, while VHI.TO trades at CA$13.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas VHI.TO's P/E ratio is 349.00. In terms of profitability, HS.CN's ROE is -1.34%, compared to VHI.TO's ROE of +0.02%. Regarding short-term risk, HS.CN is more volatile compared to VHI.TO. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check VHI.TO's competition here
HS.CN vs KSI.TO Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, KSI.TO has a market cap of 560.5M. Regarding current trading prices, HS.CN is priced at CA$0.53, while KSI.TO trades at CA$5.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas KSI.TO's P/E ratio is 590.00. In terms of profitability, HS.CN's ROE is -1.34%, compared to KSI.TO's ROE of -0.05%. Regarding short-term risk, HS.CN is less volatile compared to KSI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HS.CN.Check KSI.TO's competition here
HS.CN vs CARE.TO Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, CARE.TO has a market cap of 345.7M. Regarding current trading prices, HS.CN is priced at CA$0.53, while CARE.TO trades at CA$5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas CARE.TO's P/E ratio is -17.15. In terms of profitability, HS.CN's ROE is -1.34%, compared to CARE.TO's ROE of -0.23%. Regarding short-term risk, HS.CN is more volatile compared to CARE.TO. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check CARE.TO's competition here
HS.CN vs TRUE.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, TRUE.CN has a market cap of 36.2M. Regarding current trading prices, HS.CN is priced at CA$0.53, while TRUE.CN trades at CA$0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas TRUE.CN's P/E ratio is -2.53. In terms of profitability, HS.CN's ROE is -1.34%, compared to TRUE.CN's ROE of -9.28%. Regarding short-term risk, HS.CN is more volatile compared to TRUE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check TRUE.CN's competition here
HS.CN vs NARA.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, NARA.CN has a market cap of 21.4M. Regarding current trading prices, HS.CN is priced at CA$0.53, while NARA.CN trades at CA$1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas NARA.CN's P/E ratio is -1.95. In terms of profitability, HS.CN's ROE is -1.34%, compared to NARA.CN's ROE of +2.14%. Regarding short-term risk, HS.CN is more volatile compared to NARA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check NARA.CN's competition here
HS.CN vs UDOC.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, UDOC.CN has a market cap of 17.5M. Regarding current trading prices, HS.CN is priced at CA$0.53, while UDOC.CN trades at CA$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas UDOC.CN's P/E ratio is -2.56. In terms of profitability, HS.CN's ROE is -1.34%, compared to UDOC.CN's ROE of +6.57%. Regarding short-term risk, HS.CN is more volatile compared to UDOC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check UDOC.CN's competition here
HS.CN vs RYAH.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, RYAH.CN has a market cap of 11.2M. Regarding current trading prices, HS.CN is priced at CA$0.53, while RYAH.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas RYAH.CN's P/E ratio is -0.15. In terms of profitability, HS.CN's ROE is -1.34%, compared to RYAH.CN's ROE of +14.95%. Regarding short-term risk, HS.CN is more volatile compared to RYAH.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check RYAH.CN's competition here
HS.CN vs AIML.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, AIML.CN has a market cap of 7.8M. Regarding current trading prices, HS.CN is priced at CA$0.53, while AIML.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas AIML.CN's P/E ratio is -0.75. In terms of profitability, HS.CN's ROE is -1.34%, compared to AIML.CN's ROE of -11.81%. Regarding short-term risk, HS.CN is more volatile compared to AIML.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check AIML.CN's competition here
HS.CN vs TELE.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, TELE.CN has a market cap of 7.6M. Regarding current trading prices, HS.CN is priced at CA$0.53, while TELE.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas TELE.CN's P/E ratio is -0.13. In terms of profitability, HS.CN's ROE is -1.34%, compared to TELE.CN's ROE of +0.00%. Regarding short-term risk, HS.CN is more volatile compared to TELE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check TELE.CN's competition here
HS.CN vs LYNX.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, LYNX.CN has a market cap of 6.4M. Regarding current trading prices, HS.CN is priced at CA$0.53, while LYNX.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas LYNX.CN's P/E ratio is -0.29. In terms of profitability, HS.CN's ROE is -1.34%, compared to LYNX.CN's ROE of +0.00%. Regarding short-term risk, HS.CN is more volatile compared to LYNX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check LYNX.CN's competition here
HS.CN vs DMED.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, DMED.CN has a market cap of 4.6M. Regarding current trading prices, HS.CN is priced at CA$0.53, while DMED.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas DMED.CN's P/E ratio is -5.50. In terms of profitability, HS.CN's ROE is -1.34%, compared to DMED.CN's ROE of +6.54%. Regarding short-term risk, HS.CN is more volatile compared to DMED.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check DMED.CN's competition here
HS.CN vs LITE.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, LITE.CN has a market cap of 2M. Regarding current trading prices, HS.CN is priced at CA$0.53, while LITE.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas LITE.CN's P/E ratio is -0.50. In terms of profitability, HS.CN's ROE is -1.34%, compared to LITE.CN's ROE of -6.63%. Regarding short-term risk, HS.CN is more volatile compared to LITE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check LITE.CN's competition here
HS.CN vs CBP.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, CBP.CN has a market cap of 1.7M. Regarding current trading prices, HS.CN is priced at CA$0.53, while CBP.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas CBP.CN's P/E ratio is -1.00. In terms of profitability, HS.CN's ROE is -1.34%, compared to CBP.CN's ROE of +0.17%. Regarding short-term risk, HS.CN is more volatile compared to CBP.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check CBP.CN's competition here
HS.CN vs TMED.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, TMED.CN has a market cap of 929.3K. Regarding current trading prices, HS.CN is priced at CA$0.53, while TMED.CN trades at CA$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas TMED.CN's P/E ratio is -2.00. In terms of profitability, HS.CN's ROE is -1.34%, compared to TMED.CN's ROE of +0.28%. Regarding short-term risk, HS.CN is more volatile compared to TMED.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check TMED.CN's competition here
HS.CN vs CGN.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, CGN.CN has a market cap of 895.9K. Regarding current trading prices, HS.CN is priced at CA$0.53, while CGN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas CGN.CN's P/E ratio is -0.13. In terms of profitability, HS.CN's ROE is -1.34%, compared to CGN.CN's ROE of +0.96%. Regarding short-term risk, HS.CN is more volatile compared to CGN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check CGN.CN's competition here
HS.CN vs NDAT.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, NDAT.CN has a market cap of 619.9K. Regarding current trading prices, HS.CN is priced at CA$0.53, while NDAT.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas NDAT.CN's P/E ratio is -1.50. In terms of profitability, HS.CN's ROE is -1.34%, compared to NDAT.CN's ROE of -0.67%. Regarding short-term risk, HS.CN is more volatile compared to NDAT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check NDAT.CN's competition here
HS.CN vs KETA.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, KETA.CN has a market cap of 366.2K. Regarding current trading prices, HS.CN is priced at CA$0.53, while KETA.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas KETA.CN's P/E ratio is -1.38. In terms of profitability, HS.CN's ROE is -1.34%, compared to KETA.CN's ROE of +0.01%. Regarding short-term risk, HS.CN is more volatile compared to KETA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check KETA.CN's competition here
HS.CN vs MEND.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, MEND.CN has a market cap of 0. Regarding current trading prices, HS.CN is priced at CA$0.53, while MEND.CN trades at CA$0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas MEND.CN's P/E ratio is N/A. In terms of profitability, HS.CN's ROE is -1.34%, compared to MEND.CN's ROE of -1.68%. Regarding short-term risk, HS.CN is more volatile compared to MEND.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.Check MEND.CN's competition here
HS.CN vs WTEQ.CN Comparison August 2025
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, WTEQ.CN has a market cap of 0. Regarding current trading prices, HS.CN is priced at CA$0.53, while WTEQ.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas WTEQ.CN's P/E ratio is 2.00. In terms of profitability, HS.CN's ROE is -1.34%, compared to WTEQ.CN's ROE of -1.70%. Regarding short-term risk, Volatility data is not available for a full comparison. HS.CN has daily volatility of 3.85 and WTEQ.CN has daily volatility of N/A.Check WTEQ.CN's competition here